Finance

Lists
DMN:FRA
Diamyd Medical AB
€ ०.०६१
+०.१७%
(+०.०००१०) 1D
नोभेम्बर १७, ०८:०५:२३ GMT+१  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DMN...
Open
€ ०.०६
High
€ ०.०६
Low
€ ०.०६
Mkt. cap
१३.०० करोड
Avg. vol.
०.००
Volume
०.००
52-wk high
€ १.८०
52-wk low
€ ०.०५
No. of employees
४२
Open
€ ०.०६
High
€ ०.०६
Low
€ ०.०६
Mkt. cap
१३.०० करोड
Avg. vol.
०.००
Volume
०.००
52-wk high
€ १.८०
52-wk low
€ ०.०५
No. of employees
४२
News stories
From web sources and news partners
ChartMill
ChartMill
·
१ घण्टा पहिले
S&P 500 Premarket Movers on Nov. 17: Gainers and Losers
The Motley Fool
The Motley Fool
·
२५ मिनेट पहिले
Prediction: Dec. 9 Will Mark a Turning Point for the S&P 500
Traders Union
Traders Union
·
४२ मिनेट पहिले
S&P 500 could deliver 18% total return by 2027, Goldman Sachs projects
Profile
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for type-1 diabetes. The company's investigational drug retogatein is based on a recombinant form of GAD₆₅, one of two human glutamate decarboxylase gene products. The company is headquartered in Stockholm, and maintains a "biomanufacturing" facility in Umeå which utilizes bacuolavirus-mediated protein expression. Wikipedia
About Diamyd Medical AB
CEOUlf Hannelius
Employees४२
Founded१९८४
Headquarters-
SectorHealth Care
Industry-
Websitediamyd.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
२०२५ नोभेम्बर
२०२६ फेब्रुअरी
२०२६ मे
२०२६ अगस्ट
Revenue
२.४५ लाख
९९.०० हजार
७०.०० हजार
६५.०० हजार
Cost of goods sold
९.३८ लाख
७.८६ लाख
९.६४ लाख
७३.०० हजार
Cost of revenue
९.३८ लाख
७.८६ लाख
९.६४ लाख
७३.०० हजार
Research and development expenses
३.०५ करोड
४.५१ करोड
१०.५० करोड
-४.३९ लाख
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.६८ करोड
१.८३ करोड
१.९४ करोड
१.६३ करोड
Operating expense
४.८१ करोड
६.४३ करोड
१२.६३ करोड
१.६५ करोड
Total operating expenses
४.९१ करोड
६.५१ करोड
१२.७३ करोड
१.६६ करोड
Operating income
-४.८८ करोड
-६.५० करोड
-१२.७२ करोड
-१.६५ करोड
Other non operating income
१.०० हजार
१.०० हजार
-
-१.०० हजार
EBT including unusual items
-४.८८ करोड
-६.२९ करोड
-१२.७१ करोड
-१.६८ करोड
EBT excluding unusual items
-४.८१ करोड
-६.२९ करोड
-१२.७१ करोड
-१.६७ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-९.२५ लाख
-८.४० लाख
१.३७ लाख
-१०.६० लाख
Net income
-४.८८ करोड
-६.२९ करोड
-१२.७१ करोड
-१.६८ करोड
Net profit margin
-१९,९३६.३३%
-६३,५१३.१३%
-१,८१,५१४.२९%
-२५,८६१.५४%
Earnings per share
-
-
-
-
Interest and investment income
८.३३ लाख
२७.८० लाख
१०.६८ लाख
१७.३९ लाख
Interest expense
-६२.०० हजार
-६.३५ लाख
-९.३० लाख
-१८.९६ लाख
Net interest expenses
७.७१ लाख
२१.४५ लाख
१.३८ लाख
-१.५७ लाख
Depreciation and amortization charges
१७.८२ लाख
१७.८२ लाख
१७.३० लाख
१७.२९ लाख
EBITDA
-४.७१ करोड
-६.३२ करोड
-१२.५५ करोड
-१.४८ करोड
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू